Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chandan HealthcareNSE:CHANDAN -2.52%18 Receivables Turnover is 0.96 as of Dec. 2025. GuruFocus rates NSE:CHANDAN with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 201 Medical Diagnostics & Research companies, Chandan Healthcare ranks worse than 78.61% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Chandan Healthcare's Revenue for the
three
months ended in Dec. 2025 was ₹650 Mil. Chandan Healthcare's average Accounts Receivable for the
three
months ended in Dec. 2025 was ₹675 Mil.
Hence, Chandan Healthcare's Receivables Turnover for the
three
months ended in Dec. 2025 was 0.96.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Chandan Healthcare Receivables Turnover Related Terms
Chandan Healthcare Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Chandan Healthcare's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CHANDAN vs TMO, DHR, IDXX: Receivables Turnover Comparison
For the Diagnostics & Research subindustry, Chandan Healthcare's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandan Healthcare Receivables Turnover vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Chandan Healthcare's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Chandan Healthcare's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chandan Healthcare (NSE:CHANDAN) has a Receivables Turnover of 0.96 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Chandan Healthcare and its competitors. According to the industry distribution chart, Chandan Healthcare ranks #158 out of 201 companies in the Medical Diagnostics & Research industry, placing it in the top 78.6%.
Is Chandan Healthcare's Receivables Turnover too high?
Chandan Healthcare's current Receivables Turnover is 0.96. The Medical Diagnostics & Research industry median Receivables Turnover is 5.39. Chandan Healthcare's value of 0.96 is 82.2% below this industry median. Based on the distribution chart, Chandan Healthcare ranks #158 out of 201 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Chandan Healthcare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Chandan Healthcare's Receivables Turnover compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Chandan Healthcare ranks #158 out of 201 companies for Receivables Turnover. This places Chandan Healthcare in the lower half of its industry. The industry median Receivables Turnover is 5.39. Chandan Healthcare's value of 0.96 is 82.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Diagnostics & Research company?
The median Receivables Turnover among Medical Diagnostics & Research companies is 5.39, based on 201 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chandan Healthcare's current Receivables Turnover of 0.96 is 82.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Chandan Healthcare and its competitors. For the Medical Diagnostics & Research industry, the median Receivables Turnover is 5.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chandan Healthcare's current Receivables Turnover is 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandan Healthcare stock overvalued right now?
Chandan Healthcare (NSE:CHANDAN) has a current Receivables Turnover of 0.96. The current Receivables Turnover is 0.96 and 82.2% below the Medical Diagnostics & Research industry median of 5.39. Chandan Healthcare's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Chandan Healthcare (NSE:CHANDAN), the current Receivables Turnover is 0.96 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
18GF Score
Get the complete analysis for NSE:CHANDAN
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CHANDAN has been successfully added to your 
